儿童创新药平台也将进入申报临床研究阶段

发布于: Android转发:0回复:3喜欢:0

长春高新(SZ000661)$

Brillian Pharma Inc. is a privately owned company that specializes in drug delivery technology platforms, and process development of pediatric drug products. Brillian Pharma Inc. is based in the United States of America.

We have established an R&D laboratory and cGMP quality control laboratory in New Jersey, USA; a technology transfer center and FDA-approved manufacturing facility in Beijing, China, which is compliant with US and EU cGMP standards for product registration and commercial production; and a large-scale commercial manufacturing facility in Changchun, Jilin Province, China. Our products can be manufactured in a closed-loop system from R&D, testing, process scale-up, and registration batch production to commercial production.

小儿黄金颗粒在华康产业园设生产基地,参股的倍利年医药也将在长春新区设立生产基地

全部讨论

02-02 07:07

小儿黄金止咳似乎还没有申报上市申请

02-02 04:09

赞一下,虽然没看懂!